Category Archives: Gastroenterology

Study Design Summary: Multicenter, international placebo controlled trial of roughly 12,000 patients who were given TXA, primary outcome of death due to bleeding at 5 days. Notes: They used a slightly higher maintenance dose of (3g vs the usual 1g over 8 hours) in patients who were deemed to have a significant risk of deathContinue reading “HALT-IT: Does TXA Reduce Death in GI Bleeds”